{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T17:10:03Z","timestamp":1739121003091,"version":"3.37.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/mcg.0b013e31817236f6","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T12:29:56Z","timestamp":1242908996000},"page":"357-361","source":"Crossref","is-referenced-by-count":0,"title":["Narcotic Analgesics and Progression of Fibrosis in Patients With Chronic Hepatitis C"],"prefix":"10.1097","volume":"43","author":[{"given":"Cristian","family":"Vallejos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talya","family":"Bordin-Wosk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Pockros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Pockros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210305","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"key":"R2-12-20210305","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1002\/hep.21065","article-title":"Hepatitis C\u2013Identifying patients with progressive liver injury","volume":"43","author":"Feld","year":"2006","journal-title":"Hepatology"},{"key":"R3-12-20210305","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/hep.21078","article-title":"Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection","volume":"43","author":"Perumalswami","year":"2004","journal-title":"Hepatology"},{"key":"R4-12-20210305","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.gastro.2006.03.014","article-title":"Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data","volume":"130","author":"Leandro","year":"2006","journal-title":"Gastroenterology"},{"key":"R5-12-20210305","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/hep.21239","article-title":"Impact of obesity on treatment of chronic hepatitis C","volume":"43","author":"Charlton","year":"2006","journal-title":"Hepatology"},{"key":"R6-12-20210305","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/hep.21040","article-title":"HLA Class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C","volume":"43","author":"Patel","year":"2006","journal-title":"Hepatology"},{"key":"R7-12-20210305","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/hep.20127","article-title":"Risks of a range of alcohol intake on hepatitis C-related fibrosis","volume":"39","author":"Monto","year":"2004","journal-title":"Hepatology"},{"key":"R8-12-20210305","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1542-3565(05)00407-6","article-title":"Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis","volume":"3","author":"Huctchinson","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R9-12-20210305","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cgh.2006.03.019","article-title":"Relationship of smoking and fibrosis in patients with chronic hepatitis C","volume":"4","author":"Dev","year":"2006","journal-title":"Clinical Gastroenterol Hepatol"},{"key":"R10-12-20210305","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.20733","article-title":"Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C","volume":"42","author":"Hezode","year":"2005","journal-title":"Hepatology"},{"key":"R11-12-20210305","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/01.mlr.0000228025.04535.25","article-title":"Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996-2002","volume":"44","author":"Zerzan","year":"2006","journal-title":"Med Care"},{"key":"R12-12-20210305","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/archinte.167.2.166","article-title":"HCV & injection drug users in the United States, 1979-2002, an aging population","volume":"167","author":"Armstrong","year":"2007","journal-title":"Arch Intern Med"},{"key":"R13-12-20210305","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archinte.164.3.277","article-title":"Treating opioid dependence. Growing implications for primary care","volume":"164","author":"Krantz","year":"2004","journal-title":"Arch Intern Med"},{"key":"R14-12-20210305","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/hep.21091","article-title":"Progression of liver fibrosis among injection drug users with chronic hepatitis C","volume":"43","author":"Wilson","year":"2006","journal-title":"Hepatology"},{"key":"R15-12-20210305","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0376-8716(02)00010-8","article-title":"Treating hepatitis C in methadone maintenance patients: an interim analsyis","volume":"67","author":"Sylvestre","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"R16-12-20210305","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1086\/520093","article-title":"Morphine inhibits, intrahepatic interferon-alpha expression and enhance complete hepatitis C virus replication","volume":"196","author":"Li","year":"2007","journal-title":"J Infect Dis"},{"key":"R17-12-20210305","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0002-9440(10)61220-5","article-title":"Morphine withdrawal enhances hepatitis C replicon expression","volume":"167","author":"Wang","year":"2005","journal-title":"Am J Pathol"},{"key":"R18-12-20210305","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis. An update on terminology and reporting","volume":"19","author":"Batts","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R19-12-20210305","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2105\/AJPH.90.10.1562","article-title":"Estimating future hepatitis C morbidity, mortality, and costs in the United States","volume":"90","author":"Wong","year":"2000","journal-title":"Am J Public Health"},{"key":"R20-12-20210305","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/ijms.3.47","article-title":"The natural history of hepatitis C virus (HCV) infection","volume":"3","author":"Chen","year":"2006","journal-title":"Int J Med Sci"},{"key":"R21-12-20210305","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1002\/hep.1840360707","article-title":"Fibrosis and disease progression in hepatitis C","volume":"36","author":"Marcellin","year":"2002","journal-title":"Hepatology"},{"key":"R22-12-20210305","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/gut.52.4.574","article-title":"Measurement and determination of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study","volume":"52","author":"Wright","year":"2003","journal-title":"Gut"},{"key":"R23-12-20210305","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hep.20279","article-title":"A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance","volume":"40","author":"Mauss","year":"2004","journal-title":"Hepatology"},{"key":"R24-12-20210305","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/hep.21470","article-title":"Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implants","volume":"45","author":"Jeffrey","year":"2007","journal-title":"Hepatology"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004836-200904000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T16:40:46Z","timestamp":1739119246000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-200904000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e31817236f6","relation":{},"ISSN":["0192-0790"],"issn-type":[{"type":"print","value":"0192-0790"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}